GlassScriptPhysician profile
Jimmy D Smart
NPI 1114983897
$1,238.86
in general payments reported to CMS, 2019-2025
7 companies · $784 in 2025
The $784 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.93 · 2021: $36.13 · 2022: $68.04 · 2023: $36.95 · 2024: $290 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,110.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $759.65 | 2021-2025 | Precision 1, Total30, Precision7 |
| Bausch & Lomb Americas INC. | $204.23 | 2024-2025 | Infuse, Biotrue One Day |
| Tarsus Pharmaceuticals, INC. | $166.56 | 2024-2025 | Xdemvy |
| Rxsight INC | $45.77 | 2022-2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Johnson & Johnson Vision Care, INC. | $27.14 | 2019-2021 | |
| Dompe US, INC. | $25.19 | 2024 | Oxervate |
| Optos, INC. | $10.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Smart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.